Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
712,590,449
-
Share change
-
+871,453
-
Total reported value
-
$11,941,932,547
-
Put/Call ratio
-
53%
-
Price per share
-
$16.76
-
Number of holders
-
533
-
Value change
-
+$36,824,124
-
Number of buys
-
250
-
Number of sells
-
230
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2025
As of 30 Jun 2025,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
533 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
712,590,449 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD., Ion Asset Management Ltd., Phoenix Financial Ltd., Harel Insurance Investments & Financial Services Ltd., Clal Insurance Enterprises Holdings Ltd, Migdal Insurance & Financial Holdings Ltd., Lingotto Investment Management LLP, and Rubric Capital Management LP.
This page lists
534
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.